Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T00:41:01.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-09T20:07:26.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated to include a new clinical trial for a combination treatment involving pembrolizumab, letrozole, and palbociclib for postmenopausal patients with metastatic estrogen receptor positive breast cancer. Additionally, the page now includes a disclaimer about the U.S. government's non-review of all studies listed.
    Difference
    100%
    Check dated 2025-08-02T15:04:44.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The webpage has removed detailed information about a clinical trial for a combination treatment of breast cancer, including specifics about the study's objectives, eligibility criteria, and treatment protocols. Additionally, there are new error messages indicating server issues.
    Difference
    100%
    Check dated 2025-07-26T12:24:32.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.0%
    Check dated 2025-07-19T11:05:36.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    0.6%
    Check dated 2025-07-12T07:27:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.